(Q38196862)

30 August 2017

1 reference

title

Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications (English)

1 reference

30 August 2017

0 references

Irene Piaceri

2

0 references

Benedetta Nacmias

object named as

Benedetta Nacmias

series ordinal

4

0 references

Sandro Sorbi

object named as

Sandro Sorbi

series ordinal

3

0 references

Silvia Bagnoli

series ordinal

1

object named as

Silvia Bagnoli

1 reference

30 August 2017

1 January 2014

1 reference

Neurodegenerative disease management

30 August 2017

1 reference

30 August 2017

4

1 reference

30 August 2017

73-81

1 reference

30 August 2017

1

1 reference

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies

30 August 2017

1 reference

Genetic insights in Alzheimer's disease

21 January 2018

1 reference

Apolipoprotein E and Alzheimer disease

21 January 2018

1 reference

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

21 January 2018

1 reference

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

21 January 2018

1 reference

In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease

21 January 2018

1 reference

Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction

21 January 2018

1 reference

Neuroimaging of dementia in 2013: what radiologists need to know

21 January 2018

1 reference

Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors

21 January 2018

1 reference

Genetics of familial and sporadic Alzheimer's disease

21 January 2018

1 reference

A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.

21 January 2018

1 reference

Evidence for impaired amyloid β clearance in Alzheimer's disease

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

21 January 2018

1 reference

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

21 January 2018

1 reference

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease

21 January 2018

1 reference

New lexicon and criteria for the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.

21 January 2018

1 reference

Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use.

21 January 2018

1 reference

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

21 January 2018

1 reference

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.

21 January 2018

1 reference

EFNS task force: the use of neuroimaging in the diagnosis of dementia.

21 January 2018

1 reference

Alzheimer disease: before the diagnosis.

21 January 2018

1 reference

Imaging markers for Alzheimer disease: which vs how

21 January 2018

1 reference

Atypical dementia associated with a novel presenilin-2 mutation

21 January 2018

1 reference

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

21 January 2018

1 reference

fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease

21 January 2018

1 reference

Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele.

21 January 2018

1 reference

Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals.

21 January 2018

1 reference

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

21 January 2018

1 reference

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

21 January 2018

1 reference

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease

21 January 2018

1 reference

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

21 January 2018

1 reference

Discriminative analysis of early-stage Alzheimer's disease and normal aging with automatic segmentation technique in subcortical gray matter structures: a multicenter in vivo MRI volumetric and DTI study

21 January 2018

1 reference

21 January 2018

Sweet sixteen for ANLS.

1 reference

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

21 January 2018

1 reference

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention

21 January 2018

1 reference

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

21 January 2018

1 reference

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

21 January 2018

1 reference

Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose

21 January 2018

1 reference

Brain imaging in the study of Alzheimer's disease

21 January 2018

1 reference

Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data

21 January 2018

1 reference

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

21 January 2018

1 reference

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

Amyloid imaging with PET in early Alzheimer disease diagnosis

21 January 2018

1 reference

Clinical amyloid imaging in Alzheimer's disease

21 January 2018

1 reference

Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease

21 January 2018

1 reference

Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline

21 January 2018

1 reference

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

21 January 2018

1 reference

Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers

21 January 2018

1 reference

Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease

21 January 2018

1 reference

Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations

21 January 2018

1 reference

Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NMT.13.68

1 reference

30 August 2017

1 reference

PubMed ID

24640981